nimustine has been researched along with Esophageal Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, JH; Huang, XY; Li, Y; Wang, X; Xie, X; Yu, H; Zhang, LJ; Zhou, JL | 1 |
Ide, H; Nakamura, T | 1 |
Aoyama, N; Minamide, J; Ogata, T; Suzuki, Y; Takata, K | 1 |
Iwai, T; Kawada, K; Kawano, T; Nagai, K; Nakajima, Y; Nishikage, T; Ogiya, K; Tanaka, K; Tokairin, Y | 1 |
Haisa, M; Hara, K; Kamikawa, Y; Kenzo, A; Naomoto, Y; Perdomo, JA; Taguchi, K; Tanaka, N; Yamatsuji, T | 1 |
Akiya, Y; Hagiwara, N; Matsutani, T; Miyashita, M; Onda, M; Sasajima, K; Takubo, K; Yamashita, K | 1 |
1 review(s) available for nimustine and Esophageal Neoplasms
Article | Year |
---|---|
[Malignant melanoma of the alimentary tract].
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Diagnosis, Differential; Esophageal Neoplasms; Female; Humans; Male; Melanoma; Nimustine; Rectal Neoplasms; Vincristine | 2003 |
5 other study(ies) available for nimustine and Esophageal Neoplasms
Article | Year |
---|---|
Primary malignant melanoma of the esophagus: a study of clinical features, pathology, management and prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Nimustine; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine | 2011 |
Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Esophageal Neoplasms; Esophagectomy; Humans; Infusions, Intravenous; Interferon-beta; Male; Melanoma; Middle Aged; Nimustine; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Esophageal Neoplasms; Esophagoscopy; Female; Humans; Injections, Intralesional; Interferon-beta; Melanoma; Middle Aged; Nimustine; Vincristine | 2007 |
Primary malignant melanoma of the esophagus: report of a case successfully treated with pre- and post-operative adjuvant hormone-chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dacarbazine; Esophageal Neoplasms; Esophagectomy; Humans; Lymph Node Excision; Male; Melanoma; Middle Aged; Nimustine; Tamoxifen | 1998 |
Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Combined Modality Therapy; Dacarbazine; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Follow-Up Studies; Humans; Male; Melanoma; Nimustine; Treatment Outcome; Vincristine | 2001 |